Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SET pseudogene 2 (SETP2) is a human pseudogene, designated as a non-functional genomic segment related to the protein-coding SET gene family[1][3]. Pseudogenes such as SETP2 do not encode functional proteins due to disabling mutations, premature stop codons, or lack of regulatory elements[4]. While historically considered nonfunctional, some pseudogenes—including members of the SET family—may be transcribed into non-coding RNAs that participate in gene regulation, such as acting as microRNA decoys or scaffolds, although this has not been established specifically for SETP2[2][4][5]. There is no current evidence that SETP2 is a drug target, therapeutic receptor, or directly implicated in disease, nor are there any approved drugs, known safety concerns, or biomarker uses associated with this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SET pseudogene 2 (SETP2).